טוען...
MSI testing and its role in the management of colorectal cancer
TNM stage remains the key determinant of patient prognosis after surgical resection of colorectal cancer (CRC), and informs treatment decisions. However, there is considerable stage-independent variability in clinical outcome that is likely due to molecular heterogeneity. This variability underscore...
שמור ב:
| הוצא לאור ב: | Curr Treat Options Oncol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4594190/ https://ncbi.nlm.nih.gov/pubmed/26031544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-015-0348-2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|